F0162
Fibronectin Proteolytic Fragment from human plasma
lyophilized powder, 45 kDa
Synonym(s):
Fibronectin
Sign In to View Organizational & Contract Pricing.
Select a Size
About This Item
Form:
lyophilized powder
Assay:
≥90% (SDS-PAGE)
Biological source:
human plasma
Mol wt:
45 kDa
biological source
human plasma
assay
≥90% (SDS-PAGE)
form
lyophilized powder
mol wt
45 kDa
packaging
pkg of 0.5 mg
technique(s)
cell culture | mammalian: suitable
impurities
HIV and HBsAg, source material tested negative, Small proteolytic fragments, may contain traces
solubility
water: soluble ≥0.500 mg/mL, clear to slightly hazy, colorless
UniProt accession no.
shipped in
wet ice
storage temp.
−20°C
Quality Level
Looking for similar products? Visit Product Comparison Guide
General description
Fibronectin 1 is a glycoprotein of the extracellular matrix that is coded by FN1 gene. It is expressed in the plasma and at the cell surface.FN1 is mapped to human chromosome 2q35. Proteolytic fragments of fibronectin has a cell binding domain. Plasma fibronectin has two polypeptide chains connected by two disulphide bonds present near carboxy terminal. Each polypeptide chain is of 220-250 kDa.
Application
Fibronectin proteolytic fragment from human plasma has been used as fluorophore-conjugated proteins. It has also been used in solid phase binding assay.
Biochem/physiol Actions
Fibronectin participates in cell adhesion, growth, migration, wound healing, blood coagulation and metastasis. Mutations in FN1 results in glomerulopathy. It plays an important role in cell attachment and spreading, control of cell cytoskeleton, morphology and differentiation. FN1 is also involved in extracellular matrix formation, hemostasis and thrombosis. Proteolytic fragments of fibronectin plays a vital role in mononuclear phagocyte function.
Fibronectins are high molecular weight glycoproteins with two subunits joined by a disulfide bond to form the dimer. The fragments are obtained using protelytic enzymes. This 45 kDa gelatin binding fragment is obtained through trypitc digestion of the N-terminal 70 kDa fragment, which is produced by Cathespin D digestion.
This fragment has an acidic pI (4.9-5.3) and does not bind to heparin. This domain is resistant to proteolysis due to intrachain disulfide bonding and the attached carbohydrate. The intrachain disulfide bonds are essential for binding to gelatin, while the complex, branched, asparagine-linked carbohydrate is not. This fragment binds to C1q, but not to fibrin.
This fragment has an acidic pI (4.9-5.3) and does not bind to heparin. This domain is resistant to proteolysis due to intrachain disulfide bonding and the attached carbohydrate. The intrachain disulfide bonds are essential for binding to gelatin, while the complex, branched, asparagine-linked carbohydrate is not. This fragment binds to C1q, but not to fibrin.
Preparation Note
This product is lyophilized from phosphate buffered saline with sucrose as a cryoprotectant. The source material has tested negative for antibody to HIV, HCN, and HBsAg. It is soluble in water at 0.5 mg/mL and yields a clear to slightly hazy solution.
Disclaimer
The product should be stored at -20°C.
Storage Class
11 - Combustible Solids
flash_point_f
Not applicable
flash_point_c
Not applicable
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Nanoparticle amplification via photothermal unveiling of cryptic collagen binding sites.
Lo J H, et al.
Journal of Material Chemistry B: Materials for Biology and Medicine, 1(39), 5235-5240 (2013)
Justin H Lo et al.
Journal of materials chemistry. B, 1(39), 5235-5240 (2013-11-02)
The success of nanoparticle-based cancer therapies ultimately depends on their ability to selectively and efficiently accumulate in regions of disease. Outfitting nanoparticles to actively target tumor-specific markers has improved specificity, yet it remains a challenge to amass adequate therapy in
Fibronectin in Health and Disease (2018)
A R Pickford et al.
Structure (London, England : 1993), 5(3), 359-370 (1997-03-15)
Fibronectin is an extracellular matrix glycoprotein involved in cell adhesion and migration events in a range of important physiological processes. Aberrant adhesion of cells to the matrix may contribute to the breakdown of normal tissue function associated with various diseases.
Plasma Fibronectin: Structure and Functions (1985)
Related Content
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Contact Technical Service